Calcimimetic AMG-416 induced short-term changes in calcium concentrations and calcium isotope ratios in rats.

[1]  S. Zarogiannis,et al.  Nutritional Calcium Supply Dependent Calcium Balance, Bone Calcification and Calcium Isotope Ratios in Rats , 2022, International journal of molecular sciences.

[2]  D. Fischer,et al.  Naturally occurring stable calcium isotope ratios are a novel biomarker of bone calcium balance in chronic kidney disease. , 2022, Kidney international.

[3]  J. Bacchetta,et al.  Calcium isotope fractionation by osteoblasts and osteoclasts, across endothelial and epithelial cell barriers and with binding to proteins. , 2021, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  D. Fischer,et al.  Naturally Occurring Stable Calcium Isotope Ratios in Body Compartments Provide a Novel Biomarker of Bone Mineral Balance in Children and Young Adults , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  V. Jha,et al.  A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. , 2019, Kidney international.

[6]  R. Padidela,et al.  Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences , 2019, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[7]  K. Cashman.  Vitamin D Deficiency: Defining, Prevalence, Causes, and Strategies of Addressing , 2019, Calcified Tissue International.

[8]  W. Richards,et al.  Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration. , 2019, Kidney international.

[9]  J. Schrezenmeir,et al.  Calcium isotope ratios in blood and urine: A new biomarker for the diagnosis of osteoporosis , 2019, Bone reports.

[10]  Yasushi Hirota,et al.  Pharmacology of Parsabiv® (etelcalcetide, ONO‐5163/AMG 416), a novel allosteric modulator of the calcium‐sensing receptor, for secondary hyperparathyroidism in hemodialysis patients , 2019, European journal of pharmacology.

[11]  S. Mondal,et al.  Assessing bone mineral changes in response to vitamin D supplementation using natural variability in stable isotopes of Calcium in Urine , 2018, Scientific Reports.

[12]  K. Takeshita,et al.  Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan , 2018, BMC Musculoskeletal Disorders.

[13]  A. Levy,et al.  Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis. , 2018, Journal of comparative effectiveness research.

[14]  J. Body,et al.  Critical Reviews in Oncology/Hematology Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases , 2022 .

[15]  O. Bonny,et al.  A model of calcium homeostasis in the rat. , 2016, American journal of physiology. Renal physiology.

[16]  J. Schrezenmeir,et al.  Biological fractionation of stable Ca isotopes in Göttingen minipigs as a physiological model for Ca homeostasis in humans , 2016, Isotopes in environmental and health studies.

[17]  M. Chonchol,et al.  Renal control of calcium, phosphate, and magnesium homeostasis. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[18]  J. Bilezikian,et al.  Parathyroid hormone: anabolic and catabolic actions on the skeleton. , 2015, Current opinion in pharmacology.

[19]  A. Edwards,et al.  Regulation of calcium reabsorption along the rat nephron: a modeling study. , 2015, American journal of physiology. Renal physiology.

[20]  Ping Chen,et al.  A pharmacokinetic/pharmacodynamic model for AMG 416, a novel calcimimetic peptide, following a single intravenous dose in healthy subjects , 2014, Journal of clinical pharmacology.

[21]  D. Maclean,et al.  Comparison of AMG 416 and cinacalcet in rodent models of uremia , 2014, BMC Nephrology.

[22]  M. Peacock,et al.  Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  C. Cooper,et al.  Osteoporosis in the European Union: medical management, epidemiology and economic burden , 2013, Archives of Osteoporosis.

[24]  J. Tomlinson,et al.  Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[25]  I. D. de Boer,et al.  Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. , 2013, The Journal of clinical endocrinology and metabolism.

[26]  C. Shanahan,et al.  Mechanistic insights into vascular calcification in CKD. , 2013, Journal of the American Society of Nephrology : JASN.

[27]  Scott M Smith,et al.  Rapidly assessing changes in bone mineral balance using natural stable calcium isotopes , 2012, Proceedings of the National Academy of Sciences.

[28]  Fanxin Long,et al.  Building strong bones: molecular regulation of the osteoblast lineage , 2011, Nature Reviews Molecular Cell Biology.

[29]  S. Morony,et al.  Discovery of a Calcimimetic with Differential Effects on Parathyroid Hormone and Calcitonin Secretion , 2011, Journal of Pharmacology and Experimental Therapeutics.

[30]  J. Curtis,et al.  Medical costs of osteoporosis in the elderly Medicare population , 2011, Osteoporosis International.

[31]  D. Goltzman,et al.  Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis. , 2010, Journal of the American Society of Nephrology : JASN.

[32]  A. Eisenhauer,et al.  A pilot study on the use of natural calcium isotope (44Ca/40Ca) fractionation in urine as a proxy for the human body calcium balance. , 2010, Bone.

[33]  P. Marie.  The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. , 2010, Bone.

[34]  A. Eisenhauer,et al.  Marine Calcification: An Alkali Earth Metal Isotope Perspective , 2009 .

[35]  O. Johnell,et al.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures , 2006, Osteoporosis International.

[36]  A. Paytan,et al.  Calcium isotope fractionation in modern scleractinian corals , 2006 .

[37]  J. Kunkel,et al.  Bone as an ion exchange organ: evidence for instantaneous cell-dependent calcium efflux from bone not due to resorption. , 2005, Bone.

[38]  D. Riccardi,et al.  Ca2+ as an extracellular signal in bone. , 2004, Cell calcium.

[39]  A. Parfitt,et al.  Misconceptions (3): calcium leaves bone only by resorption and enters only by formation. , 2003, Bone.

[40]  L. Ferrucci,et al.  Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. , 2002, Journal of the American Society of Nephrology : JASN.

[41]  G. Hendy,et al.  Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  D. DePaolo,et al.  Calcium isotope fractionation between soft and mineralized tissues as a monitor of calcium use in vertebrates. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Boland,et al.  Parathyroid hormone stimulates calcium influx and the cAMP messenger system in rat enterocytes. , 1997, American journal of physiology. Cell physiology.

[44]  S. Laxminarayan,et al.  Circadian Rhythms of Blood Minerals during Adolescence , 1984, Pediatric Research.

[45]  L. Rotkin,et al.  Circadian rhythms of blood minerals in humans. , 1981, Science.

[46]  J. Staub,et al.  Endogenous nature of circadian rhythms in calcium metabolism. , 1979, The American journal of physiology.

[47]  J. Reeve.  THE TURNOVER TIME OF CALCIUM IN THE EXCHANGEABLE POOLS OF BONE IN MAN AND THE LONG‐TERM EFFECT OF A PARATHYROID HORMONE FRAGMENT , 1978, Clinical endocrinology.

[48]  C. J. Robinson.  The physiology of parathyroid hormone. , 1974, Clinics in endocrinology and metabolism.

[49]  I. Nemere,et al.  Does PTH have a direct effect on intestine? , 2002, Journal of cellular biochemistry.